Elevated Intracranial Pressure: Mannitol or Hypertonic Saline First
A hardware-store owner arrives with a large basal ganglia hemorrhage and a sluggish, dilating pupil. The osmotic agent chosen in the next ten minutes has to work with his kidneys and his blood pressure, not just his brain.
R.D., a 58-year-old man, has run the same hardware store on Main Street for two decades and was restocking a shelf of paint cans when an employee heard him say his head hurt worse than anything he'd ever felt, then found him slumped against the ladder minutes later. He arrived forty minutes ago unresponsive, and the emergency department's first exam already told most of the story before the scan confirmed it: a right pupil at 5mm, reactive but sluggish — not the fixed, blown pupil of complete herniation, but the narrow window just before it, the point where osmotic therapy still changes what happens next rather than only documenting the decline.
The CT explains the pupil: a 40mL basal ganglia bleed with 6mm of midline shift, exactly the volume and location where transtentorial herniation follows a predictable, short timeline if nothing intervenes. His history complicates which osmotic agent gets there fastest and safest. Twelve years of hypertension, managed on lisinopril he admits he takes "most of the time," has already left his baseline creatinine mildly elevated — today's 1.4 is not acutely different, but it is a kidney with less reserve than a clean one. He is also tachycardic and dry, volume-down rather than volume-replete, likely from hours of vomiting before anyone found him. Mannitol works as an osmotic diuretic, pulling free water out through kidneys that already have less margin, and the diuresis itself would deepen a volume deficit he does not have room for. Hypertonic saline raises serum osmolality by adding solute rather than removing volume — mechanistically the better fit for a hypovolemic, mildly renal-impaired patient, a distinction Cottenceau and colleagues' 2011 randomized trial in severe TBI found translated into a real difference: at equiosmolar doses, hypertonic saline produced a greater and more sustained ICP reduction than mannitol. That trial randomized two separate groups — 20% mannitol against 7.5% saline — so what it establishes is the class comparison, not a result about the 3% concentration a single peripheral line can actually take.
Ten minutes before the OR
Hypertonic saline, and not mannitol, given who this patient actually is rather than the textbook default. He's dry — tachycardic, poor mucous membrane turgor — and mildly renal-impaired at baseline. An osmotic diuretic pulls volume out through kidneys that already have less reserve, and it does that on top of a deficit he's already running. Hypertonic saline adds solute without asking his kidneys to excrete anything acutely; it's the mechanism that fits this patient's volume status, not just his ICP.
I don't disagree with the physiology — you're right that his volume status argues against a diuretic. But we have one peripheral line and no central access, and he's going to the OR the moment this shift stops progressing. A mannitol bolus runs peripherally at full concentration in minutes. Three percent saline peripherally is fine, but if we're waiting on central access to give 23.4% for a bigger effect, that's time his pupil doesn't have.
You're both solving for the right variable and talking past each other on it. Be precise about what Cottenceau shows: two randomized groups, 20% mannitol against 7.5% saline, with the saline arm getting the greater and longer ICP reduction at equal osmolar load. That's a class result, not a result about 3%. But the class result is the part that transfers to him — adding solute beats pulling volume out of a man who is already dry — and 3% is the concentration a peripheral line will take without waiting on central access. We don't need 23.4% to get a real effect here, and we don't need mannitol's diuresis on a volume-down kidney. Three percent saline, peripheral, now, with a second line placed en route to the OR for anything further.
Three percent hypertonic saline, 250mL, ran through the existing peripheral line within two minutes of the decision. His pupil narrowed to 4mm and briskly reactive by the time he reached the OR twenty minutes later, and the surgical team evacuated the hematoma with the shift already partially relieved rather than worsening.
Not fully settled: whether 23.4% HTS through a central line placed first would have reversed the pupillary change faster than 3% saline given immediately — the neurosurgeon still holds that a few extra minutes for central access might have been worth a stronger initial bolus, a position the outcome here didn't have to test. Sodium is being checked every four hours through the immediate postoperative period given the volume of hypertonic saline given peripherally.